Nicotinell 14mg NICOTINE PATCHES 7 24H is a drug to treat tobacco dependence. The 14mg/24h Nicotinell patches relieve the symptoms of nicotine withdrawal, are used in the early treatment of moderate smokers or intermediate phase of heavy smokers.
Ships in 5-7 business days
Warning: Last items in stock!
Availability date:Preview the Shipping Fees - Free Shipping from 99€*
For warnings, the precautions and cons-indications, please see the instructions.
Nicotinell 14mg NICOTINE PATCHES 7 24H
Description Nicotinell 14mg NICOTINE PATCHES 7 24H
Patch Nicotinell 14mg/24h laboratories Novartis is a medicine that contains nicotine, only for adults from 15 years and indicated for the treatment of tobacco dependence in order to relieve the symptoms of nicotine withdrawal in patients wishing to stop their smoking.
- After application of the patch, the nicotine is gradually released and pass into the blood stream via the skin.
- No contact with other harmful substances contained in tobacco smoke (carbon monoxide, tar, stimulants gas ...).
- Nicotine decreases withdrawal symptoms (urgent desire for a cigarette, irritability, moodiness, anxiety, feelings of fear, hunger, weight gain, difficulty concentrating, sleep disorders ...).
Very discreet, Nicotinell Patch 14mg/24h is for early treatment of moderate smokers (including cigarette consumption does not exceed 20 cigarettes per day) or intermediate processing heavy smokers (including cigarette smoking over 20 cigarettes per day). It continually releases (over 24 hours) of nicotine and reduces the urgent desire of the first cigarette in the morning. It helps to stop smoking, reduces the unpleasant effects of deprivation and the craving.
Application advice and opinions on Nicotinell 14mg NICOTINE PATCHES 7 24H
Nicotinell Patch 14mg/24h sticks once a day and 24 hours remain on the skin:
- Change location every day to avoid skin irritations.
- Remove the protective film.
- Apply the patch to clean skin, smooth, dry and healthy (with no trace of lotion, ointment or alcohol), preferably on the chest or on the upper arm.
- Hold the patch by pressing with the palm of the hand for about 10 seconds.
- During handling, avoid contact with eyes, nose and wash your hands after application.
Heavy smokers (including cigarette smoking over 20 cigarettes per day):
- Patch Nicotinell 21mg/24h over a period of about 4 weeks, then a Nicotinell Patch 14mg/24h duration additional four weeks and then Nicotinell 7mg/24h Patch for a period of about four weeks.
Smokers with an average consumption (including cigarette consumption does not exceed 20 cigarettes per day.)
- Nicotinell Patch 14mg/24h for about 8 weeks, then Nicotinell Patch 7mg/24h for about 4 weeks.
- Dosing of the transdermal system should be tailored to the individual response: increase dose if smoking abstinence is not complete or if withdrawal symptoms are observed decrease in case of suspected overdose.
- The treatment period is about 3 months, but may vary depending on the individual response. It is recommended not to use this medication beyond 6 months.
- Adolescents should use Nicotinell Patch that if strong tobacco addiction and after consulting a doctor or pharmacist.
Composition Nicotinell 14mg NICOTINE PATCHES 7 24H
1 Nicotinell patch contains 35 mg nicotine - The average release of the active ingredient on the skin of 14 mg/24 h.
A transdermal device (20 cm ²): S (-) Nicotine 35 mg. Excipients: copolymer alkali methacrylate (Eudragit E 100), qs 1 transdermal patch. Outer shell: polyester film. Matrix layer: DuroTak 280-2516, Miglyol 812, Eudragit E 100 Support nonwoven. Paper. Adhesive layer: DuroTak 280-2516, miglyol removable protective sheet 812. Aluminized polyester silicone movie.
Precaution for use with Nicotinell 14mg NICOTINE PATCHES 7 24H
This medication is against-indicated in the following situations: Non-smoker or occasional smoker; Hypersensitivity to any component; Skin condition that may interfere with the use of a transdermal patch.
Introducing Nicotinell 14mg NICOTINE PATCHES 7 24H
Box of 7 Patches Nicotinell 14mg/24h.
Our expert advice pharmacy
Warnings and other precautions for use:
- To ensure the best chances of success, the use of this drug should be accompanied by a complete cessation of tobacco use.
- Due to the pharmacological effects of nicotine, some conditions require medical advice and medical monitoring: hepatic and / or renal failure severe; gastric or duodenal ulcer development.
- Nicotine is a toxic substance: Keep this medication out of reach of children. Indeed, the therapeutic dose for adults could cause serious poisoning or death in children.
- It is recommended to fold the patch to itself before throwing.
- If severe or persistent skin reaction, it is recommended to stop the treatment and use a different pharmaceutical form (see Adverse Reactions).
- Experimental studies in several species have shown no teratogenic or foetotoxic effect of nicotine administered continuous flow and that at maternally toxic doses. Under the same conditions of administration, fetal growth retardation is observed at even higher doses in one case, the mice but not in rats or rabbits. Clinically comments yet limited number show no deleterious impact maternal or fetal nicotine used in the indication of smoking cessation.
- Smoking during pregnancy can cause a delay of intra-uterine growth, fetal death in utero of prematurity, an SGA, which seem to correlate with the importance of impregnation smoking as well as the period of pregnancy, because these effects are observed when the tobacco impregnation continues for the third quarter.
- Nicotine provided by substitution treatment is not without deleterious effects on the fetus, as evidenced by the observed hemodynamic consequences. It is however no epidemiological study indicating the real impact of nicotine provided by substitution treatment on the fetus or newborn.
- Pregnant woman should always recommend a complete stop smoking, free treatment to nicotine.
- In case of failure at a heavily dependent patient, smoking cessation is possible with this medication. Indeed, the risk to the fetus in case of continued smoking during pregnancy is likely higher than expected with nicotine replacement therapy, as is superimposed with tobacco exposure to polycyclic hydrocarbons and the carbon monoxide, and since the exposure provided by nicotine replacement therapy is or is not lower than that associated to tobacco consumption.
- The objective is to achieve complete cessation or substitution treatment before the third trimester of pregnancy. Smoking cessation, with or without substitution treatment should not be considered in isolation, but within the framework of a comprehensive care, taking into account the psycho-social context and other addictions possibly associated. It may be desirable to use a consulting firm specializing in smoking cessation.
- In case of partial or complete failure of weaning, continued treatment with a nicotine replacement after the 6th month of pregnancy can not be considered case by case. One should keep in mind the specific effects of nicotine, which may sound on the fetus, especially when near term.
- Given the constant concentrations of nicotine with this form of substitution, breastfeeding is not recommended during treatment with this medicine.
Interaction with other medicinal products and other forms of interaction:
- Tobacco may, by enzyme induction process due to aromatic hydrocarbons, decrease blood levels of certain drugs such as caffeine, theophylline, tricyclic antidepressants, flecainide, pentazocine.
- Stop, let alone brutal, tobacco, especially on the occasion of taking this medicine may increase the concentrations of these active ingredients related to the reversibility of the effect of enzyme induction.
- For drugs with a narrow therapeutic index, such as theophylline, smoking cessation should be accompanied, in addition titration, closely monitored, clinical or biological information with the patient risk of overdose.
- By their specific, cardiovascular, neurological and endocrine pharmacological properties of nicotine may, as tobacco: cause increased levels of cortisol and catecholamines; require a dose adjustment of nifedipine, beta-blockers, insulin; reduce the effect of diuretics; slowing the rate of healing of gastric ulcers by H2 antihistamines; increase the incidence of adverse estroprogestatifs.
- Transdermal nicotine can cause side effects similar to nicotine administered by other modes.
- Systemic side effects: palpitations. Dizziness, headache. Nausea, vomiting. Insomnia, blurred dreamlike.
- Local adverse reactions: erythema and itching at the application site, rarely edema, burning sensation.
- These effects are largely moderate majority and resolve spontaneously soon after system removal.
- If severe or persistent skin reaction, it is recommended to stop the treatment and use another form of nicotine replacement therapy.
- Symptoms such as dizziness some, headache and insomnia may be related to smoking cessation.
- An increase in the occurrence of oral ulcers can occur after smoking cessation. The causal relationship is not clear.
Nicotine overdose can occur if the treated patient had previously very low nicotine intake or if used concomitantly with other treatments for smoking cessation nicotine.
- Overdose symptoms are those of acute nicotine poisoning include nausea, salivation, abdominal pain, diarrhea, sweating, headache, dizziness, loss of hearing and general weakness. At high doses may appear hypotension, weak and irregular pulse, breathing difficulties, prostration, circulatory collapse and convulsions.
- Doses of nicotine tolerated by smoking subjects during treatment can lead to acute poisoning can be fatal in young children.
What to do in case of overdose:
- The administration of nicotine should be discontinued immediately and symptomatic treatment should be initiated.
- Assisted ventilation and oxygen therapy will be undertaken if necessary.
Warnings on drugs
Warning, the drug is not a product like any other. Read the package leaflet before ordering. Do not leave medicines out of reach of children. If symptoms persist, seek the advice of your doctor or pharmacist. Attention to incompatibilities on products in your.
Tell your pharmacist online treatments underway to identify possible incompatibilities. The checkout form contains a custom message field provided for this purpose.
Click here to find record of the drug at the site of the National Security Agency of Medicines and Health Products.
Pharmacovigilance : Report or a related adverse event (s) (s) (s) the use of a drug
Save time by using the quick order form. With a few clicks , you can easily order your favorite references.
Be fan of our Facebook page and get 5 % discount!
If you are not logged in to Facebook, please first log in and then refresh this page before clicking the Like button. Otherwise, you will not get your voucher.